Express Scripts Holding Company (NasdaqGS:ESRX) overview
United States of America/
Healthcare Services/
NasdaqGS:ESRX
about: Level Biotechnology Inc (GTSM:3118)
industry group: Healthcare Services
from: Taiwan about: AmerisourceBergen Corporation (NYSE:ABC)
industry group: Healthcare Services
from: United States of America
industry group: Healthcare Services
from: Taiwan about: AmerisourceBergen Corporation (NYSE:ABC)
industry group: Healthcare Services
from: United States of America
| Financial Parameter Name | Value |
|---|---|
| company name | Express Scripts Holding Company (NasdaqGS:ESRX) |
| exchange ticker | NasdaqGS:ESRX |
| industry group | Healthcare Services |
| country | United States of America |
| broad group | United States |
| sub group | United States |
| bottom up beta for sector | 0.7177 |
| bottom up levered beta | 0.8326 |
| erp for country | 5.00 |
| cost of equity usd | 7.20 |
| total default spread for cost of debt | 1.50 |
| pre tax cost of debt usd | 4.54 |
| after tax cost of debt usd | 2.72 |
| cost of capital usd | 6.30 |
| roe cost of equity | 0.92 |
| roic cost of capital | 39.20 |
| market cap usd | 56599.40 |
| pv of lease debt | 238.87 |
| total debt | 14113.60 |
| total debt incl leases usd | 14352.47 |
| firm value usd | 70951.87 |
| cash | 1722.30 |
| enterprise value usd | 69229.57 |
| cash firm value | 2.43 |
| liquidity ratio | 0.01 |
| book debt to capital ratio | 37.70 |
| market debt to capital ratio | 20.23 |
| book debt to equity ratio | 60.51 |
| market debt to equity ratio | 25.36 |
| stock price on dec 31 2012 usd | 70.24 |
| beta | 0.98 |
| correlation with market | 49.40 |
| standard deviation in stock price | 52.64 |
| hilo risk measure | 0.14 |
| interest coverage ratio | 7.62 |
| current pe | 43.11 |
| trailing pe | 30.65 |
| forward pe | 14.85 |
| peg | 2.69 |
| pbv | 2.39 |
| ps | 0.60 |
| ev ebit | 16.03 |
| ev ebitda | 13.13 |
| ev invested capital | 9.83 |
| ev sales | 0.74 |
| payout ratio | 0.00 |
| dividend yield | 0.00 |
| historical growth in net income 3 yrs | 19.80 |
| historical growth in net income 5 yrs | 21.10 |
| historical growth in revenues 3 yrs | 36.20 |
| historical growth in revenues 5 yrs | 36.90 |
| expected growth rate in eps 5 yrs | 16.00 |
| expected growth in revenues 2 yrs | 5.06 |
| return on equity | 8.12 |
| return on capital roc or roic | 45.50 |
| net profit margin | 1.75 |
| pre tax operating margin | 4.08 |
| effective tax rate | 36.89 |
| percent held by institutions | 88.16 |
| net income | 1312.90 |
| trailing net income | 1846.80 |
| operating income | 4263.50 |
| trailing operating income adj for leases | 4319.33 |
| revenues | 93858.10 |
| trailing revenues | 105826.30 |
| ebitda | 5274.60 |
| trailing ebitda | 6552.50 |
| ebit 1 t | 2725.78 |
| net debt issued debt issue repaid | 2931.60 |
| change in non cash working capital | -472.50 |
| net cap ex | -1124.00 |
| reinvestment rate | -58.57 |
| fcff | 4322.28 |
| fcfe | 511.70 |
| fcfe without debt | 3443.30 |
| book value of equity 4 qtrs ago | 22744.90 |
| invested capital 4 qtrs ago | 9492.77 |
| current book value of equity | 23719.10 |
| current invested capital | 7042.97 |
| dividends | 0.00 |
| modified 2 yr beta | 1.04 |
| modified 5 yr beta | 1.09 |
| beta adjustment factor | 1.08 |
| coeff of variation op income | 0.07 |
| coeff of variation net income | 0.06 |
| average 10 yr ebit | 1444.57 |
| average 10 yr net income | 734.41 |
| dividends and buybacks | -1552.50 |
| crp | 0.00 |
| country marginal tax rate | 0.00 |
about: Level Biotechnology Inc (GTSM:3118)
industry group: Healthcare Services
from: Taiwan about: AmerisourceBergen Corporation (NYSE:ABC)
industry group: Healthcare Services
from: United States of America
industry group: Healthcare Services
from: Taiwan about: AmerisourceBergen Corporation (NYSE:ABC)
industry group: Healthcare Services
from: United States of America